Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
J Nematol ; 52: 1-4, 2020.
Article in English | MEDLINE | ID: mdl-32436669

ABSTRACT

Samples of galled roots, resembling those induced by root-knot nematodes, and rhizosphere soil were collected from potted plants of Ulmus parvifolia cvs. Allee and Drake in Lake County, Florida. Nematode species were identified using both molecular analysis and morphology of perineal patterns. Meloidogyne enterolobii and M. javanica were identified from U. parvifolia cv. Allee. Meloidogyne arenaria and M. javanica were identified from U. parvifolia cv. Drake. This is a first report of these nematode species infecting Chinese Elm in Florida.Samples of galled roots, resembling those induced by root-knot nematodes, and rhizosphere soil were collected from potted plants of Ulmus parvifolia cvs. Allee and Drake in Lake County, Florida. Nematode species were identified using both molecular analysis and morphology of perineal patterns. Meloidogyne enterolobii and M. javanica were identified from U. parvifolia cv. Allee. Meloidogyne arenaria and M. javanica were identified from U. parvifolia cv. Drake. This is a first report of these nematode species infecting Chinese Elm in Florida.

2.
J Nematol ; 52: 1-3, 2020.
Article in English | MEDLINE | ID: mdl-32141268

ABSTRACT

In October 2019, samples of galled roots with rhizosphere soil were collected from declining Elaeocarpus decipiens in Hernando County, Florida. Extracted root-knot nematodes were identified by both molecular and morphological methods as Meloidogyne enterolobii. This is a first report of this regulated root-knot nematode on Elaeocarpus decipiens in Florida.In October 2019, samples of galled roots with rhizosphere soil were collected from declining Elaeocarpus decipiens in Hernando County, Florida. Extracted root-knot nematodes were identified by both molecular and morphological methods as Meloidogyne enterolobii. This is a first report of this regulated root-knot nematode on Elaeocarpus decipiens in Florida.

3.
Br J Cancer ; 109(12): 3034-41, 2013 Dec 10.
Article in English | MEDLINE | ID: mdl-24178758

ABSTRACT

BACKGROUND: Persin is a plant toxin that displays synergistic cytotoxicity with tamoxifen in human breast cancer cell lines. Here, we examined the ability of persin to circumvent tamoxifen resistance and delineated the intracellular signalling pathways involved. METHODS: The induction of apoptosis in tamoxifen-resistant and -sensitive breast cancer cells was measured by flow cytometry following treatment with persin±tamoxifen. Markers of endoplasmic reticulum stress (ERS) were analysed following treatment, and their causal role in mediating persin-induced apoptosis was determined using chemical inhibitors and RNA interference. RESULTS: Cells that were resistant to an apoptotic concentration of tamoxifen maintained an apoptotic response to persin. Persin-induced apoptosis was associated with an increase in markers of ERS, that is, CHOP expression and XBP-1 splicing and was decreased by CHOP siRNA. The CASP-4 inhibitor Z-YVAD-FMK markedly inhibited persin-induced apoptosis in both tamoxifen-sensitive and -resistant cells. CONCLUSION: The cytotoxic effects of persin are CASP-4 dependent and mediated by CHOP-dependent and -independent ERS signalling cascades. Increased ERS signalling contributes to persin-induced reversal of tamoxifen resistance.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Breast Neoplasms/drug therapy , Endoplasmic Reticulum Stress/drug effects , Fatty Alcohols/pharmacology , Plant Extracts/pharmacology , Tamoxifen/pharmacology , Apoptosis/drug effects , Apoptosis/physiology , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Line, Tumor , Drug Resistance, Neoplasm , Drug Synergism , Fatty Alcohols/administration & dosage , Female , Humans , MCF-7 Cells , Signal Transduction , Tamoxifen/administration & dosage
4.
Oncogene ; 30(28): 3186-97, 2011 Jul 14.
Article in English | MEDLINE | ID: mdl-21383694

ABSTRACT

Recognition of the pivotal role of estrogen in the aetiology of breast cancer has led to the development of antiestrogens (AE), such as tamoxifen (TAM) as effective therapies for the treatment and prevention of this disease. However, despite their widespread clinical efficacy, response to AEs is often short-lived, and acquired or innate therapeutic resistance remains a major obstacle in the successful treatment of breast cancer. Thus, delineating the intracellular pathways that mediate the cellular response to estrogen could potentially lead to new, more effective approaches to the treatment of breast cancer, particularly endocrine-resistant disease. Here, we have identified the BCL-2 homology 3 (BH3)-only, pro-apoptotic regulator, PUMA (p53 upregulated modulator of apoptosis) as an estrogen target gene that is acutely downregulated in response to estrogen in breast cancer cell lines, independently of their p53 status. PUMA is transcriptionally upregulated following treatment with TAM, and knock down of PUMA expression in these cells attenuates the apoptotic response to TAM. Furthermore, low PUMA expression in breast carcinomas is significantly associated with breast cancer-specific death (P=0.0014 and P=0.0115, for mRNA and protein, respectively), and worse outcome in TAM-treated patients (mRNA, P=1.49e-05). These findings suggest that the dysregulation of apoptotic signaling pathways such as those executed through PUMA, can significantly impact on both the progression and therapeutic responsiveness of breast cancer. Moreover, they provide a convincing rationale for exploring new therapeutic approaches involving endocrine and non-endocrine therapies that target apoptotic pathways as an effective strategy for tackling endocrine refractory disease.


Subject(s)
Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Apoptosis/drug effects , Breast Neoplasms/drug therapy , Estrogen Antagonists/pharmacology , Estrogens/pharmacology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Tamoxifen/pharmacology , Adult , Aged , Aged, 80 and over , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Cell Line, Tumor , Cohort Studies , Disease Progression , Down-Regulation/drug effects , Estradiol/pharmacology , Estrogen Antagonists/therapeutic use , Estrogens/metabolism , Gene Expression Regulation, Neoplastic/drug effects , Humans , Middle Aged , RNA, Messenger/genetics , RNA, Messenger/metabolism , Tamoxifen/analogs & derivatives , Tamoxifen/therapeutic use , Transcription, Genetic/drug effects , Treatment Outcome , Young Adult
5.
Gut ; 55(12): 1697-703, 2006 Dec.
Article in English | MEDLINE | ID: mdl-16527835

ABSTRACT

BACKGROUND: Atrophy of the smooth muscle layers of the muscularis propria characterises oesophageal involvement in systemic sclerosis (scleroderma). The aetiology of this atrophy and of the resultant oesophageal dysfunction is unknown. OBJECTIVES: To examine oesophageal tissue for evidence of fibrosis, vascular disease, inflammatory reactions and neural abnormalities to determine the possible causes of this disease process. METHODS: A case-control survey was conducted using oesophageal tissue from 74 scleroderma cases and 74 age, race and sex-matched controls from our autopsy files. Histological evidence of oesophageal muscle atrophy was correlated with the degree of vascular changes, inflammatory infiltration, fibrosis, abnormalities of the myenteric plexus and reduction of interstitial cells of Cajal (ICC) using a predesigned semiquantitative descriptive method. RESULTS: Smooth-muscle atrophy was found in 94% of scleroderma cases, and in 5% of controls (p<0.001). Atrophy was evident in the circular smooth muscle in 93% of cases, and in the longitudinal smooth muscle in 66% of cases. Intimal proliferation of arterioles was found in 38% of cases and in 5% of controls (p<0.001), but was not associated with smooth-muscle atrophy (p = 0.29). Despite these vascular changes, there was no evidence of compromised perfusion, such as findings suggestive of acute ischaemic necroses. Minimal cellular infiltrates were seen in the myenteric plexus in 82% of cases and in 92% of controls (p = 0.091). ICC were found in fewer numbers in areas of atrophic smooth muscle compared with adjacent normal smooth muscle in selected scleroderma cases. CONCLUSION: The pathological findings of oesophageal lesions in scleroderma seem inconsistent with either an ischaemic or an inflammatory process. The loss of circular and longitudinal smooth muscle in the distal scleroderma oesophagus may represent loss of normal neural function followed by secondary tissue atrophy, or may be a primary smooth muscle lesion.


Subject(s)
Esophageal Diseases/pathology , Scleroderma, Systemic/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Autopsy , Case-Control Studies , Child , Esophageal Diseases/complications , Esophagus/blood supply , Esophagus/pathology , Female , Humans , Immunohistochemistry/methods , Male , Middle Aged , Mucous Membrane/pathology , Muscle, Smooth/pathology , Muscular Atrophy/complications , Muscular Atrophy/pathology , Myenteric Plexus/pathology , Scleroderma, Systemic/complications
6.
AIDS Res Hum Retroviruses ; 16(1): 67-76, 2000 Jan 01.
Article in English | MEDLINE | ID: mdl-10628818

ABSTRACT

Conventional analysis of the cytotoxic T lymphocyte (CTL) response to HIV-1 may underestimate the true breadth of CTL epitopes recognized. This underestimation could be due to several reasons, including (1) the use of laboratory-adapted stains of HIV or consensus sequences, which would lead to the identification of only highly conserved epitopes, (2) the use of EBV-transformed B cells (B-LCLs) and vaccinia virus constructs in standard assays that may obscure low level CTL responses due to high EBV or vaccinia reactivity, and (3) relatively insensitive assays wherein PBMCs instead of professional APCs are used to stimulate CTL responses. To address these problems, we first identified an immunodominant HLA-B7-restricted CTL epitope, by standard cloning methods, in a long-term nonprogressor (LTNP). To determine whether the patient had CTLs specific for autologous viral sequences other than the dominant epitope, proviral DNA was cloned and sequenced. A matrix-based epitope algorithm (EpiMatrix) was used to identify the top 2% of peptides from the viral sequences with the highest likelihood of binding to HLA-B7. These 55 peptides were synthesized and tested for HLA-B7 binding in a T2/B7 cell line; 10 peptides were able to stabilize HLA-B7 on the cell surface. By using peptide-pulsed autologous dendritic cells as a more sensitive method of CTL stimulation, we found three additional subdominant CTL epitopes.


Subject(s)
Algorithms , Dendritic Cells/immunology , Epitopes, T-Lymphocyte/analysis , HIV Infections/immunology , HIV-1/immunology , Immunodominant Epitopes/analysis , T-Lymphocytes, Cytotoxic/immunology , Computer Simulation , Epitopes, T-Lymphocyte/immunology , Gene Products, gag/immunology , HIV Infections/virology , HIV-1/genetics , HLA-B7 Antigen/immunology , Humans , Immunodominant Epitopes/immunology
7.
J Hematother ; 7(5): 431-6, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9829317

ABSTRACT

The cost of harvesting, processing, and freezing multiple peripheral blood stem cell (PBSC) products could easily exceed that of bone marrow harvest. To reduce costs while maintaining product viability, we examined the effect of overnight storage on PBSC products. Sixteen consecutive leukapheresis samples from 12 patients were examined prospectively. Each initial leukapheresis product was stored overnight on ice (median temperature 15 degrees C) after adding an equal amount of M199 culture medium containing heparin. After overnight storage, the product was combined with the next day PBSC harvest if required and processed/frozen per protocols. Parameters measured before and after storage include cell count and differential, viability, bacterial cultures, and colony-forming unit (CFU) assays. The results show that the median cell concentration during storage was 7.12 x 10(7)/ml and the median length of storage was 20 h. After storage, the median viability and nucleated cell recovery were 100% and 99.5%, respectively. In addition, 98% recovery of CFU-GM was achieved. No clotting or bacterial contamination was detected. All 12 patients studied engrafted promptly. In addition, 124 similarly treated patients were retrospectively analyzed. Of these, 48% required > or = 2 large-volume leukaphereses to achieve the target cell dose. As a result of overnight storage, 150 final products, instead of 224, were processed and cryopreserved. This difference is equivalent to 33% cost savings. Again, all patients were transplanted and engrafted successfully. In conclusion, overnight storage and pooling of two consecutive PBSC products are safe, reduce cost, and allow for optimum laboratory staffing.


Subject(s)
Hematopoietic Stem Cell Mobilization , Hematopoietic Stem Cell Transplantation , Adolescent , Adult , Blood Preservation , Cell Survival , Child , Costs and Cost Analysis , Graft Survival , Hematopoietic Stem Cell Mobilization/economics , Hematopoietic Stem Cell Mobilization/methods , Humans , Middle Aged , Transplantation, Autologous
8.
J Infect Dis ; 178(5): 1317-26, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9780251

ABSTRACT

The ARIEL Project for the Prevention of HIV Transmission from Mother to Infant was established to evaluate virologic and immunologic parameters during vertical transmission. To determine the strength and breadth of the cytotoxic T lymphocyte (CTL) response and its correlation with human immunodeficiency virus (HIV) transmission, a cross-sectional study was done of 31 HIV-infected pregnant women, of whom 15 transmitted and 16 did not transmit HIV to their infants. The precursor frequencies of CTL specific for HIV-1 gag, pol, nef, and env from 5 different isolates of the clade B of HIV-1 were determined by limiting dilution analysis. Results showed that variable levels of HIV-specific CTL response were present in HIV-infected pregnant women during and after pregnancy. In addition, CTL precursor frequencies specific for pol and nef were higher during pregnancy in nontransmitters than in transmitters. Thus, CTL responding to different HIV antigens may not be contributing equally to the prevention of vertical transmission.


Subject(s)
HIV Infections/transmission , Infectious Disease Transmission, Vertical , T-Lymphocytes, Cytotoxic/immunology , Adult , CD4 Lymphocyte Count , Cross Reactions , Cross-Sectional Studies , Female , Gene Products, env/immunology , HIV Antigens/immunology , HIV Infections/immunology , HIV-1 , Humans , Infant, Newborn , Longitudinal Studies , Pregnancy , RNA, Viral/analysis
9.
Cytometry ; 34(3): 121-7, 1998 Jun 15.
Article in English | MEDLINE | ID: mdl-9696156

ABSTRACT

Conventional flow cytometric methods for CD34+ cell counting may be affected by the high number of nucleated red blood cells or nonviable cells in cord blood and its products. We developed a simple flow cytometric no-wash procedure that avoids these shortcomings because it provides absolute CD34+ cell counts and assesses cell viability. Samples were incubated with phycoerythrin (PE)-labeled anti-CD34 (Becton Dickinson Immunocytometry Systems [BD], San Jose, CA) and peridinin chlorophyll protein (PerCP)-labeled anti-CD45 (BD) in bead-containing TRUCOUNT tubes (BD). After red cell lysis with a fixative-free reagent, the impermeant nucleic acid dye YO-PRO-1 (Molecular Probes, Eugene, OR) was added and samples were analyzed on a single-laser FACSCalibur (BD). A comparison with the ProCOUNT progenitor cell assay (BD) in 57 samples revealed excellent correlation of results (r = 0.98, intercept -0.2 cells/microl, slope 1.01). Precision studies conveyed coefficients of variation of 6.4 and 8.9% at concentrations of 35 and 16 CD34+ cells/microl, respectively. In untreated and leukocyte-enriched cord blood 4.5+/-3.8% of CD34+ cells were stained by YO-PRO-1, representing apoptotic or necrotic cells. In post-thawing cryopreserved samples this number increased to 10.4+/-5.5%. Isotype controls showed very low blank values of viable cells (0.1+/-0.4 cells/microl, maximum 2.4) and seemed unnecessary. We found no washing-related alteration of results in 35 samples, indicating that the method may also be performed with cell washing. Replacing YO-PRO-1 with TO-PRO-3 facilitated four-color analysis of subpopulations of viable CD34+ cells on a FACSCalibur equipped with a second (diode) laser. We found the proposed method to be a rapid, efficient, and flexible procedure that improved validity of CD34+ cell counts.


Subject(s)
Antigens, CD34/analysis , Fetal Blood/cytology , Flow Cytometry/methods , Fluorescent Dyes/analysis , Hematopoietic Stem Cells/cytology , Leukocyte Count , Leukocytes, Mononuclear/cytology , Cell Survival , Hematopoietic Stem Cells/immunology , Humans , Infant, Newborn , Leukocytes, Mononuclear/immunology , Microspheres , Reproducibility of Results
10.
AIDS Res Hum Retroviruses ; 12(7): 593-610, 1996 May 01.
Article in English | MEDLINE | ID: mdl-8743085

ABSTRACT

Identification of promiscuous or multideterminant T cell epitopes is essential for HIV vaccine development, however, current methods for T cell epitope identification are both cost intensive and labor intensive. We have developed a computer-driven algorithm, named EpiMer, which searches protein amino acid sequences for putative MHC class I- and/or class II-restricted T cell epitopes. This algorithm identifies peptides that contain multiple MHC-binding motifs from protein sequences. To evaluate the predictive power of EpiMer, the amino acid sequences of the HIV-1 proteins nef, gp160, gag p55, and tat were searched for regions of MHC-binding motif clustering. We assessed the algorithm's predictive power by comparing the EpiMer-predicted peptide epitopes to T cell epitopes that have been published in the literature. The EpiMer method of T cell epitope identification was compared to the standard method of synthesizing short, overlapping peptides and testing them for immunogenicity (overlapping peptide method), and to an alternate algorithm that has been used to identify putative T cell epitopes from primary structure (AMPHI). For the four HIV-1 proteins analyzed, the in vitro testing of EpiMer peptides for immunogenicity would have required the synthesis of fewer total peptides than either AMPHI or the overlapping peptide method. The EpiMer algorithm proved to be more efficient and more sensitive per amino acid than both the overlapping peptide method and AMPHI. The EpiMer predictions for these four HIV proteins are described. Since EpiMer-predicted peptides have the potential to bind to multiple MHC alleles, they are strong candidates for inclusion in a synthetic HIV vaccine.


Subject(s)
Algorithms , Epitopes, T-Lymphocyte/immunology , HIV Antigens/immunology , HIV-1/immunology , Amino Acid Sequence , Evaluation Studies as Topic , Gene Products, env/immunology , Gene Products, gag/immunology , Gene Products, nef/immunology , Gene Products, tat/immunology , HIV Envelope Protein gp160 , Humans , Molecular Sequence Data , Protein Precursors/immunology , nef Gene Products, Human Immunodeficiency Virus , tat Gene Products, Human Immunodeficiency Virus
11.
Hum Reprod ; 10(8): 2139-41, 1995 Aug.
Article in English | MEDLINE | ID: mdl-8567855

ABSTRACT

Human oocytes which failed to fertilize in vitro were fixed for cytogenetic analysis. Metaphase II chromosomes were identified in 286 oocytes, of which 233 were suitable for cytogenetic analysis. In all, 181 oocytes had a normal haploid karyotype (77.7%), while the remaining 52 were abnormal (28 aneuploid, 14 diploid and 10 tetraploid). The rate of aneuploidy did not increase with maternal age. However, the proportion of diploid oocytes increased significantly with advancing maternal age (P < 0.01), being particularly obvious in women aged > 35 years.


Subject(s)
Diploidy , Fertilization in Vitro , Maternal Age , Oocytes/physiology , Pregnancy, High-Risk , Adult , Aneuploidy , Female , Haploidy , Humans , Karyotyping , Treatment Outcome
12.
Vaccine ; 13(6): 581-91, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7483779

ABSTRACT

We have designed two computer-based algorithms for T cell epitope prediction, OptiMer and EpiMer, which incorporate current knowledge of MHC-binding motifs. OptiMer locates amphipathic segments of protein antigens with a high density of MHC-binding motifs. EpiMer identifies peptides with a high density of MHC-binding motifs alone. These algorithms exploit the striking tendency for MHC-binding motifs to cluster within short segments of each protein. Putative epitopes predicted by these algorithms contain motifs corresponding to many different MHC alleles, and may contain both class I and class II motifs, features thought to be ideal for the peptide components of synthetic subunit vaccines. In this study, we describe the use of OptiMer and EpiMer for the prediction of putative T cell epitopes from Mycobacterium tuberculosis and human immunodeficiency virus protein antigens, and demonstrate that these two algorithms may provide sensitive and efficient means for the prediction of promiscuous T cell epitopes that may be critical to the development of vaccines against these and other pathogens.


Subject(s)
Algorithms , Epitopes/analysis , HIV Antigens/immunology , Major Histocompatibility Complex/immunology , Mycobacterium tuberculosis/immunology , T-Lymphocytes/immunology , Animals , Antigens, Bacterial/immunology , Binding Sites , Epitopes/immunology , Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens Class I/metabolism , Histocompatibility Antigens Class II/immunology , Histocompatibility Antigens Class II/metabolism , Mice , Predictive Value of Tests
13.
Aust N Z J Obstet Gynaecol ; 34(2): 185-8, 1994 May.
Article in English | MEDLINE | ID: mdl-7980310

ABSTRACT

This study reports the effect of an inherited (X;6) translocation which has not previously been described. The proband was intellectually delayed and had ovarian dysgenesis. Karyotyping revealed an unbalanced karyotype: 46,X,der(X)t(X;6)(q22; p11.2)*. Her mother was shown to be a carrier of an apparently balanced translocation between the X chromosome and chromosome 6: 46,X,t(X;6)(q22;p11.2). This finding in the mother raises to 7 the number of cases reported which involve a break within the X chromosome 'critical region', at band Xq22, without causing ovarian dysgenesis, although it was associated with premature ovarian failure. These cases aim to highlight to clinical specialists the range of gonadal and other phenotypic anomalies (apart from those associated with Turner syndrome) which can occur due to partial deletions of the X chromosome. These findings have implications for the investigation of both ovarian dysgenesis and premature ovarian failure.


Subject(s)
Chromosomes, Human, Pair 6 , Gonadal Dysgenesis/genetics , Ovary/abnormalities , Primary Ovarian Insufficiency/genetics , Translocation, Genetic , X Chromosome , Adult , Female , Humans , Karyotyping
14.
Clin Orthop Relat Res ; (286): 198-205, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8425345

ABSTRACT

A double-blind trial of pulsed electromagnetic fields (PEMFs) for loosened cemented hip prostheses was conducted at two centers. Of the 40 patients who enrolled, 37 met entry criteria and were available for analysis. All patients completed six months of treatment (either active or control units). Success was determined clinically by a Harris hip score greater than or equal to 80 points (or an increase of ten points if initially greater than or equal to 70 points). Ten of the 19 active units were successes (53%), whereas two of the 18 controls (11%) exhibited a placebo effect, a statistically significant and clinically relevant result. A 60% relapse rate among the active successes was seen at 14 months poststimulation, and despite maintenance therapy of one hour per day, the relapse rate increased to 90% at three years. These data suggest that for loosened cemented hip prostheses, use of PEMFs is a treatment option only to delay revision hip surgery.


Subject(s)
Electric Stimulation Therapy/methods , Electromagnetic Fields , Hip Prosthesis , Adult , Aged , Double-Blind Method , Female , Humans , Male , Middle Aged , Prosthesis Failure , Recurrence
15.
ASAIO J ; 38(2): 116-9, 1992.
Article in English | MEDLINE | ID: mdl-1421604

ABSTRACT

Sterilization of tissue based medical devices via cold sterilization processes has been limited to formaldehyde, glutaraldehyde, and mixtures of the same with alcohols and surfactants. The authors report the sterilization of a small caliber vascular graft with a combination of diglycidyl ether and ethanol. The sterilant contains 1-4% diglycidyl ether and 10-20% ethanol as an aqueous solution. Sterilization is achieved after exposure of the graft to the sterilant solution for a period of 7 days at an elevated temperature (30 degrees - 40 degrees C). The biologic indicator selected for efficacy studies was Bacillus subtilis niger ATCC 9372 (endospores). The grafts were inoculated with a concentrated endospore suspension and immersed in the sterilant solution for increasing time periods. After extensive rinsing over membrane filters to remove any residual sterilant, the grafts and filters were cultured in tryptic soy broth. D10 values were calculated using a fraction-negative, most probable number technique. Additionally, many representative bacteria and fungi were tested and found to be susceptible to the new sterilant developed. The diglycidyl ether/alcohol sterilant developed was found to be efficacious for sterilization of the tissue based vascular grafts tested.


Subject(s)
Blood Vessel Prosthesis , Epoxy Compounds , Ethanol , Sterilization , Bacteria/growth & development , Temperature
16.
Reprod Fertil Dev ; 4(4): 387-98, 1992.
Article in English | MEDLINE | ID: mdl-1461990

ABSTRACT

Platelet activating factor (PAF) is an ether phospholipid produced by preimplantation embryos of a number of species. Production of PAF by embryos has been measured by detecting thrombocytopenia in a splenectomized mouse bioassay, platelet aggregation bioassays in vitro and a specific radioimmunoassay. Production is highly variable and is adversely affected by culture in vitro. It has, however, been correlated with morphology, development rates in vitro and the pregnancy potential of embryos following transfer. Investigations using PAF-antagonists have established an essential role for PAF in early pregnancy. Together with studies that have shown PAF to have direct effects on embryonic metabolism during culture in vitro, these observations suggest that PAF acts as an embryonic autocoid. Hence, a major site of action for embryo-derived PAF in vivo is the embryo itself. Supplementation of embryo culture media with PAF had no effect on the rate of development in vitro of 2-cell mouse embryos through to the blastocyst stage. However, PAF increased cell numbers of blastocysts cultured from the 2-cell stage and the mitotic index of embryos at both the 8-cell and blastocyst stages. Supplementation of culture media with PAF has also been shown to increase the implantation potential of both mouse and human embryos cultured in vitro. In the mouse, the effect of PAF in enhancing implantation rates was most evident when the developmental potential of untreated embryos was suboptimal. These observations suggest that the production of embryo-derived PAF is one limiting factor in maintaining the viability of embryos cultured in vitro.


Subject(s)
Blastocyst/drug effects , Platelet Activating Factor/pharmacology , Animals , Blastocyst/metabolism , Embryo Implantation/drug effects , Embryo Implantation/physiology , Embryonic and Fetal Development/drug effects , Embryonic and Fetal Development/physiology , Female , Humans , In Vitro Techniques , Mice , Platelet Activating Factor/physiology , Pregnancy , Sheep , Species Specificity
17.
Cancer Genet Cytogenet ; 48(2): 243-53, 1990 Sep.
Article in English | MEDLINE | ID: mdl-2397455

ABSTRACT

With the use of a short-term tissue culture method, 27 solid ovarian tumor specimens (from 22 patients) were successfully karyotyped. The majority of the specimens were from serous carcinoma (18 specimens, 2 of which were not invasive). Adenocarcinomas (two specimens), two endometrioid carcinomas, and one each of clear cell, mucinous, sarcoma, squamous carcinoma, and an unclassified sex cord carcinoma were also analyzed. The specimens showed marked cytogenetic heterogeneity, ranging from a normal karyotype (46,XX) to very grossly aneuploid, with multiple rearrangements. All chromosomes, excepting 13, 15, 19, 20, and 21 were positively identified in at least one rearrangement. Chromosomes 1, 6, and 7 were most commonly involved. Identified rearrangements were not limited to one carcinoma type. The most common deletions of 1p and 6q were identified in both serous carcinoma and adenocarcinoma. Deletion of 7q,(del(7)(q32)), was observed only in serous carcinoma but was limited to three patients. Correlations of modal chromosome count and number of marker chromosomes appeared to be associated with good prognosis for patients with serous carcinoma.


Subject(s)
Chromosome Aberrations , Ovarian Neoplasms/genetics , Adult , Aged , Female , Gene Rearrangement , Humans , Middle Aged , Ovarian Neoplasms/mortality , Prognosis , Survival Rate
18.
Cancer Genet Cytogenet ; 48(1): 53-60, 1990 Aug 01.
Article in English | MEDLINE | ID: mdl-2372788

ABSTRACT

Cytogenetic analyses of solid tumors are hampered both by the difficulties in preparing high-quality banded metaphases and the high degree of karyotypic heterogeneity. Three specimens were obtained from a single patient with serous carcinoma for karyotyping and compared to determine whether the tumor was multifocal or metastatic. All three specimens were hypodiploid, sharing marker chromosomes, thus indicating metastasis. To simplify comparison between the specimens, a diagram of the inferred cytogenetic evolution of the cells analysed was developed. This method afforded a simple means of comparing the different tumor sites in a single patient and might also be applied to sequential samples from patients.


Subject(s)
Chromosome Aberrations , Ovarian Neoplasms/genetics , Chromosome Banding , Clone Cells , DNA, Neoplasm/genetics , Female , Flow Cytometry , Genetic Markers , Humans , Karyotyping , Ovarian Neoplasms/pathology , Ovarian Neoplasms/secondary
19.
Hum Reprod ; 3(8): 990-2, 1988 Nov.
Article in English | MEDLINE | ID: mdl-3060480

ABSTRACT

A reliable method for the fixation of large numbers of preimplantation embryos was developed to allow application of routine G-banding methods to preimplantation stage embryos. The technique resulted in minimal loss of embryos and was suitable for both 1-cell mouse embryos and multi-pronuclear human embryos. Application of this method will increase the information gained from chromosome studies of embryonic development.


Subject(s)
Blastocyst/cytology , Chromosome Banding/methods , Animals , Cytological Techniques , Female , Humans , Karyotyping/methods , Mice
20.
Cancer Genet Cytogenet ; 27(1): 9-13, 1987 Jul.
Article in English | MEDLINE | ID: mdl-3581044

ABSTRACT

Cytogenetic studies of human solid tumor tissue are hampered by poor quality preparations. Using a method of short-term tissue culture developed for ovarian carcinoma specimens, we have obtained large numbers of high quality metaphases suitable for analysis from 19 of 28 ovarian tumors studied.


Subject(s)
Metaphase , Ovarian Neoplasms/pathology , Chromosome Aberrations , Culture Techniques , Female , Humans , Karyotyping , Ovarian Neoplasms/genetics
SELECTION OF CITATIONS
SEARCH DETAIL